通过CCL1-介导的M1巨细胞聚合,GTSF1促进子宫癌的干性
Ying Li1, Ting Lan1, Mengyuan Liu1
1Department of Obstetrics and Gynecology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University Wuxi 214023, Jiangsu, China.
American journal of cancer research
|June 16, 2025
概括
在子宫癌 (UCS) 中GTSF1表达升高与生存率差相关. GTSF1通过激活CCL1来促进瘤的入侵和干性,CCL1会招募M1巨细胞并增加IL-6,从而推动癌症的侵袭性进展.
科学领域:
- 妇科瘤学 妇科瘤学
- 癌症免疫学 癌症免疫学
- 分子瘤学分子瘤学
背景情况:
- 子宫癌 (UCS) 是一种罕见的,有侵略性的子宫内膜癌,预后不佳.
- 了解驱动UCS进展的分子机制对于开发有效疗法至关重要.
研究的目的:
- 研究GTSF1在UCS进展中的作用及其对瘤微环境的影响.
- 为了确定治疗这种侵袭性恶性瘤的潜在治疗点.
主要方法:
- 在UCS患者样本中分析GTSF1表达.
- 在体外研究评估了GTSF1对瘤细胞表型的影响.
- 与巨细胞进行共同培养实验,以评估免疫细胞相互作用.
- 多重复合免疫组织化学分析瘤组织.
主要成果:
- 升高的GTSF1表达与UCS患者的无病生存期 (DFS) 降低有关.
- GTSF1增强了瘤细胞的入侵,迁移和干状性质.
- GTSF1激活了CCL1,促进了M1巨细胞的招募和IL-6的分泌,从而放大了癌症的干细胞性.
- GTSF1,CCL1和M1巨细胞在UCS组织中表现出共同局部.
结论:
- GTSF1通过调节瘤免疫微环境来驱动UCS的进展.
- 针对GTSF1及其下游信号通路 (CCL1/巨/IL-6轴) 提供了潜在的治疗策略.
- 这项研究为针对侵袭性子宫癌的多模式治疗方法提供了翻译性见解.
相关概念视频
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Metastasis
5.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K
Mesenchymal Stem Cells
5.0K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.0K
Cancer Stem Cells and Tumor Maintenance
5.1K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.1K


